Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice

Psychopharmacology

Volumn 133, Issue 1, 1997, Pages 43-50

  Geter Douglass, Beth ^a   Witkin, Jeffrey M ^a  

^a NIDA Addiction Research Center   (United States)

Author keywords

ACPC; CGS 19755; CPP; Dextrorphan; Dizocilpine; Drug discrimination; Ifenprodil; LY 233536; LY 235959; LY 274614; Mice; NBQX; NMDA receptor antagonists; NPC 17742; Phencyclidine; SKF 10,047; T maze; TCP

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; COCAINE; DECAHYDRO 6 (2H TETRAZOL 5 YLMETHYL) 3 ISOQUINOLINECARBOXYLIC ACID; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEXTRORPHAN; DIAZEPAM; DIZOCILPINE; IFENPRODIL; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BINDING SITE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG POTENCY; ENANTIOMER; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULUS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BINDING, COMPETITIVE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030826163     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050369     Document Type: Article

References (45)

1. Anthony EW, Nevins, M.E (1993) Anxiolytic effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. Eur J Pharmacol 250: 317-324
2. Balster RL, Willetts J (1988) Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists . In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin, pp 122-135
3. Balster RL, Nicholson KL, Sanger DJ (1994) Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend 35: 211-216
4. Balster RL, Mansbach RS, Shelton LL, Nicholson KL, Grech DM, Wiley JL, Li H, Weber E (1995) Behavioural pharmacology of two novel substituted quinozalinedione glutamate antagonists. Behav Pharmacol 6: 577-590
5. Baron SP, Woods, JH (1995) Competitive and uncompetitive N-methyl-D-aspartate antagonists discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology 118: 42-51
6. Bullock R (1995) Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann NY Acad Sci 765: 272-278
7. Carter A (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther 269: 573-580
8. Cory-Slechta DA (1995) MK-801 subsensitivity following post-weaning lead exposure. Neuro Toxic 16: 83-96
9. DeVry J, Traber J (1989) Discriminative stimulus properties of the noncompetitive NMDA antagonist MK-801 in the rat. Soc Neurosci Abstr 15[2]: 1166
10. Ferkany JW, Kyle DJ, Willetts J, Rzeszotarski WJ, Guzewska ME, Ellenberger SR, Jones SM, Sacaan AI, Snell LD, Borosky S, Jones BE, Johnson KM, Balster RL, Burchett K, Kawasaki K, Hoch DB, Dingledine R (1989) Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist. J Pharmacol Exp Ther 250: 100-109
11. France CP, Woods JH, Ornstein P (1989) The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. Eur J Pharmacol 159: 133-139
12. France CP, Moerschbaecher JM, Woods JH (1991) MK-801 and related compounds in monkeys: Discriminative stimulus effects and effects on a conditional discrimination. J Pharmacol Exp Ther 257: 727-734
13. Ginski MJ, Witkin JM (1994) Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology 114: 573-582
14. 9-Tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian gerbil (Meriones unguiculatus). Pharmacol Biochem Behav 3: 403-410
15. Koek W, Colpaert, FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by the NMDA antagonists and putative glycine antagonists: relationships with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252: 349-357
16. Koek W, Woods JH, Jacobson AE, Rice KC (1987) Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP. Psychopharmacology 93: 437-442
17. Koek W, Colpaert FC, Woods JH, Kamenka J-M (1989) The phencyclidine (PCP) analog of N-[1-(2-benzo(B)thiophenyl)cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J Pharmacol Exp Ther 250: 1019-1027
18. Kolesnikov YA, Maccechini M-L, Pasternak GW (1994) 1-Amino-cyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55: 1393-1398
19. Leeson PD, Iversen LL (1994) The glycine site and the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem 37: 4053-4067
20. Litchfield JT, Wilcoxon, F (1949) A simplified method for evaluating dose-effect experiments. J Pharmacol Exp Ther 95: 99-113
21. Meldrum B (1985) Possible therapeutic application of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68: 113-123
22. Olney J (1989) Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26: 505-525
23. Ouagazzal A, Amalric, M (1995) Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism. Eur J Pharmacol 294: 137-146
24. Overton DA (1982) Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology 76: 385-395
25. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following antidepressant treatments. J Pharmacol Exp Ther 296: 95-102
26. Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P (1995) NMDA antagonist properties of the putative antiaddictive drug ibogaine. J Pharmacol Exp Ther 275: 753-760
27. Przegalinski E, Tatarczynska E, Deren-Wesolek A, Chojnacka-Wojcik E (1996) Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. Pharmacol Biochem Behav 54: 73-77
28. Roberts PJ, Porter RHP (1995) Characterization and modulation of binding to the glutamate receptor. In: Stone TW (ed) CNS neurotransmitters and neuromodulators: glutamate. CRC Press, Boca Raton, pp 66-82
29. Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325-331
30. Sanger DJ, Zivkovic B (1989) The discriminative stimulus effects of MK-801: generalization to other N-methyl-D-aspartate receptor antagonists. J Psychopharmacol 3: 198-204
31. Scatton B (1993) The NMDA receptor complex. Fundam Clin Pharmacol 7: 389-400
32. Singh L, Menzies R, Tricklebank MD (1990) The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. Eur J Pharmacol 186: 129-132
33. Skolnick P, Marvizon JCG, Jackson BW, Monn JA, Rice KC, Lewin AH (1989) Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci 45: 1647-1655
34. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16: 165-174
35. Tricklebank MD, Singh L, Oles RJ, Wong EHF, Iversen S (1987) A role of N-methyl-D-aspartate acid in the discriminative stimulus properties of phencyclidine. Eur J Pharmacol 141: 497-501
36. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167: 127-135
37. Troupin AS, Mendius JR, Cheng F, Risinger MW (1986) MK-801. In: Meldrum B, Porter R (eds) New anticonvulsant drugs. Libbey, London, pp 191-201
38. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38: 139-154
39. Willetts J, Balster RL (1988) The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Neuropharmacology 27: 1249-1256
40. Willetts J, Clissold DB, Hartman TL, Brandsgaard RR, Hamilton GS, Ferkany JW (1993) Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. J Pharmacol Exp Ther 265: 1055-1062
41. Witkin JM (1995) Role of NMDA receptor in behavior and behavioral effects of drugs. In: Stone TW (ed) CNS neurotransmitters and neuromodulators: glutamate. CRS Press, Boca Raton, pp 323-350
42. Witkin JM, Brave S, French D, Geter-Douglass B (1995) Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 275: 1267-1273
43. Witkin JM, Steele TD, Sharpe LG (1997) Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J Pharmacol Exp Ther 280: 46-52
44. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50: 274-281
45. Xu X, Klinger P, Davis R (1995) Comparative anterograde amnestic and anticonvulsant effects of two types of NMDA receptor antagonists: MK-801 and HA-966. Psychopharmacology 117: 333-339